Physician profile
Morgan Johnson
NPI 1619759784
$4,874.30
in general payments reported to CMS, 2019-2025
22 companies · $2,602 in 2025
The $2,602 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $197 · 2024: $2,075 · 2025: $2,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,591 · Education: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,591.22 |
| Education | $283.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,067.23 | 2023-2025 | |
| Janssen Biotech, INC. | $613.78 | 2024-2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $543.02 | 2024-2025 | Zoryve |
| Amgen INC. | $425.59 | 2024-2025 | Otezla, Otezla |
| Leo Pharma INC. | $356.57 | 2023-2025 | Adbry |
| Incyte Corporation | $284.67 | 2024-2025 | Opzelura |
| Ucb, INC. | $242.57 | 2024-2025 | Bimzelx |
| Pfizer INC. | $223.15 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $222.14 | 2024-2025 | Sotyktu |
| Genzyme Corporation | $213.17 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $164.61 | 2024-2025 | Dupixent, Libtayo |
| Organon LLC | $102.14 | 2025 | Vtama |
| Sanofi-Aventis U.S. LLC | $99.00 | 2025 | |
| Dermavant Sciences, INC. | $86.23 | 2024 | Vtama |
| Galderma Laboratories, L.P. | $66.25 | 2025 | Nemluvio |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $42.47 | 2024-2025 | Ycanth |
| Lilly USA, LLC | $27.15 | 2025 | Taltz, Ebglyss |
| Sun Pharmaceutical Industries INC. | $23.64 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.44 | 2025 | Cabtreo |
| Novartis Pharmaceuticals Corporation | $19.32 | 2024 | |
| Botanix Sb INC | $16.89 | 2025 | Sofdra |
| Almirall LLC | $15.27 | 2025 | Klisyri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.